Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Experience in local hyperthermia with using ThermaTech 2000--second report].

K Mitsuno, T Agishi, H Nakazawa

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |August 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein.

    The New England journal of medicine·1995
    Same author

    Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

    Annals of neurology·1995
    Same author

    Purification and characterization of platelet-activating factor acetylhydrolase II from bovine liver cytosol.

    The Journal of biological chemistry·1995
    Same author

    cDNA cloning of human cytosolic platelet-activating factor acetylhydrolase gamma-subunit and its mRNA expression in human tissues.

    Biochemical and biophysical research communications·1995
    Same author

    Response of human gingival fibroblasts to prostaglandins.

    Journal of periodontal research·1995
    Same author

    Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

    Stroke·1995

    OK-432 shows potential as an immunoheat potentiator for cancer treatment, improving tumor response in some patients. However, severe side effects necessitate the development of improved agents.

    Area of Science:

    • Oncology
    • Immunotherapy
    • Biomedical Engineering

    Context:

    • Effective hyperthermia treatment for large, deep tumors remains challenging.
    • Current anticancer drugs show limited efficacy in advanced and metastatic cancers.
    • OK-432 is investigated as a potential agent to enhance hyperthermia therapy.

    Purpose:

    • To evaluate OK-432 as an immunoheat potentiator for cancer treatment.
    • To assess the efficacy and side effects of OK-432 in combination with hyperthermia.
    • To compare the response rates of OK-432 with conventional chemotherapy.

    Summary:

    • Hyperthermia treatment struggles to adequately heat large, deep tumors.
    • OK-432, used with radio-frequency hyperthermia, demonstrated minor responses in 3/3 evaluable patients with advanced/metastatic tumors.

    Related Experiment Videos

  • Conventional chemotherapy showed no change in 11/16 patients and progressive disease in 5/16.

    • Impact:

    • OK-432 shows promise as an immunoheat potentiator, offering a potential new therapeutic strategy.
    • The study highlights the need for improved immunoheat potentiators due to OK-432's severe side effects (chills, fever).
    • Further research is warranted to develop safer and more effective agents for enhanced hyperthermia cancer treatment.